Arrowhead Research reported $452.27M in Equity Capital and Reserves for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Agios Pharmaceuticals AGIO:US $ 1207.45M 84.52M
Alnylam Pharmaceuticals ALNY:US $ 176.04M 225.13M
Anika Therapeutics ANIK:US $ 286.15M 0.37M
Arrowhead Research ARWR:US $ 452.27M 79.71M
Bluebird Bio BLUE:US $ 263.26M 111.02M
Cerulean Pharma CERU:US $ 30.88M 7.88M
Heron Therapeutics HRTX:US $ 23.96M 53.61M
Intercept Pharmaceuticals ICPT:US $ -369.83M 1.93M
IONIS PHARMACEUT IONS:US $ 709.57M 62.16M
Ligand Pharmaceuticals LGND:US $ 793.19M 27.97M
Moderna Inc MRNA:US 17.98B 910M
Nektar Therapeutics NKTR:US $ 607.89M 71.62M
Novartis NOVN:VX SF 62925M 1385M
Opko Health OPK:US $ 1614.88M 70.24M
Sarepta Therapeutics SRPT:US $ 726.46M 130.43M
Spectrum Pharmaceuticals SPPI:US $ 55.26M 7.7M
Tg Therapeutics TGTX:US $ 170.39M 66.77M
Ultragenyx Pharmaceutical RARE:US $ 678.07M 118.35M
Vertex Pharmaceuticals VRTX:US $ 10907M 807M
Xencor XNCR:US $ 742.34M 20.68M
YTE INCY:US $ 4085.06M 221.99M